Marathon Asset Management CEO Bruce Richards on Monday said he's bullish on Wells Fargo. Here's why.

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / WHY: New York, N.Y., June 9, 2025.

Carolina Milanesi, president and principal analyst at Creative Strategies, says Apple opening up its AI to developers allows for the company to prep for the future. She speaks with Ed Ludlow on “Bloomberg Tech.

High-yield stocks that trade at deep discounts to NAV often attract value-oriented income investors. However, most of the time, these investments are value traps. I share two popular stocks like this whose dividends I think are at risk and will likely deliver disappointing total returns to shareholders moving forward.

Dell's Michael Dell discusses the 'Trump Account' that's a part of Congress' latest budget bill.

Apple Inc. unveiled a new operating system interface called Liquid Glass at its annual Worldwide Developers Conference, an event that focused heavily on aesthetics and design elements rather than software breakthroughs. Bloomberg's Ed Ludlow was there and reports.

Legendary American design icons blend signature engineering and architectural styles JACKSON CENTER, Ohio , June 9, 2025 /PRNewswire/ -- Airstream® , the iconic manufacturer of world-class recreational vehicles, and the Frank Lloyd Wright Foundation have partnered to debut the Airstream Frank Lloyd Wright Usonian Limited Edition Travel Trailer. A tribute to American design and organic architecture, the limited-edition travel trailer personifies Frank Lloyd Wright's unmatched architectural vision and Airstream Founder Wally Byam's innovative approach to mobile living and the pursuit of travel freedom.

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/iovance-biotherapeutics-inc-class-action-lawsuit.

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE:OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action.

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Reddit, Inc. (NYSE:RDDT) for potential violations of the federal securities laws. If you invested in Reddit, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/reddit-inc-securities-fraud-class-action.

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Civitas Resources, Inc. (NYSE:CIVI) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Civitas you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/civitas-resources-inc.

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Diversified Holdings and Compass Group Diversified Holdings, LLC (NYSE:CODI) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Compass you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/compass-diversified-holdings.

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ:FTRE) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit.

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ:URGN) and certain of the Company's senior executives for potential violations of the federal securities laws.

The Food and Drug Administration approved Merck's shot designed to protect infants from respiratory syncytial virus during their first season of the virus. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead of the RSV season that typically kicks off around fall and winter.

NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=152321&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.

IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, today announced the formation of MUSE Veterinary Digital Pathology , LLC, a wholly-owned subsidiary focused on transforming pathology through point-of-care service. This initiative aims to provide same-day results for tissue biopsies. This new service will provide the gold standard of patient care allowing veterinarians to deliver pet parents with diagnosis, prognosis, and treatment plans efficiently using the SmartPath MUSE Technology™ (SmartPath)* Platform.

Science Applications International's NYSE: SAIC share price imploded following Donald Trump's election to the U.S. Presidency and is now offering a screaming hot entry for investors.

eToro Group Ltd (NASDAQ:ETOR) has been given a ‘Neutral' rating and a 12-month price target of $70, reflecting modest upside, in initial coverage from analysts at UBS. The bank's analysts view eToro as a key beneficiary of the surge in global retail investor activity, particularly outside the United States.